Genetic and environmental factors determining clinical outcomes and cost of warfarin therapy: a prospective study-Reference-Cited by-同舟云学术

Genetic and environmental factors determining clinical outcomes and cost of warfarin therapy: a prospective study

Published:2009-10 Issue:10 Volume:19 Page:800-812
ISSN:1744-6872
Container-title:Pharmacogenetics and Genomics
language:en
Short-container-title:

Author:

Jorgensen Andrea L.,Al-Zubiedi Sameh,Zhang Jieying Eunice,Keniry Andrew,Hanson Anita,Hughes Dyfrig A.,Eker Diane van,Stevens Lisa,Hawkins Karen,Toh Cheng H.,Kamali Farhad,Daly Ann K.,Fitzmaurice David,Coffey Alison,Williamson Paula R.,Park Brian Kevin,Deloukas Panos,Pirmohamed Munir

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Genetics (clinical),Genetics,Molecular Biology,Molecular Medicine,General Pharmacology, Toxicology and Pharmaceutics

Reference55 articles.

1. Oral anticoagulants versus antiplatelet therapy for preventing stroke in patients with non-valvular atrial fibrillation and no history of stroke or transient ischemic attacks;Aguilar;Cochrane Database Syst Rev,2007

2. Major bleeding complications in a specialized anticoagulation service;Fanikos;Am J Cardiol,2005

3. Pharmacogenetics of warfarin: current status and future challenges;Wadelius;Pharmacogenomics J,2007

4. A polymorphism in the VKORC1 gene is associated with an interindividual variability in the dose-anticoagulant effect of warfarin;D'Andrea;Blood,2005

5. Association of polymorphisms in the cytochrome P450 CYP2C9 with warfarin dose requirement and risk of bleeding complications;Aithal;Lancet,1999

Cited by 56 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact of CYP2C19 gene polymorphisms on warfarin dose requirement: a systematic review and meta-analysis;Pharmacogenomics;2022-11

2. Pharmacogenetics of Praziquantel Metabolism: Evaluating the Cytochrome P450 Genes of Zimbabwean Patients During a Schistosomiasis Treatment;Frontiers in Genetics;2022-06-08

3. External Evaluation of a Bayesian Warfarin Dose Optimization Based on a Kinetic-Pharmacodynamic Model;Biological and Pharmaceutical Bulletin;2022-01-01

4. Effect of NPC1L1 polymorphism on warfarin stable dose in Chinese patients under heart valve replacement surgery;Clinical and Experimental Pharmacology and Physiology;2021-10-13

5. Effect of gene polymorphism on bleeding complications in Chinese Han patients taking warfarin;European Journal of Clinical Pharmacology;2021-10-01